Wyeth Korea, Inc. (Baek-Hee Kang, Representative Director and President) is a multi-national pharmaceutical company established in 1982 through collaboration with American Cyanamid and Yuhan Corporation. The company has been active as an affiliated company to Wyeth-Ayerst International, Inc., a division of the ethical business of AHP, since the take-over of American Cyanamid by AHP (American Home Products), a worldwide known research-oriented pharmaceutical company, in 1994. Its trade name was changed from Yuhan Cyanamid to Wyeth Korea as of September 1, 2000 for the new jump.
AHP has changed its name to Wyeth to refloect its role as a global research-driven pharmaceutical company committed to solving the world's health problems through leading-edge biotechnology, effective March 11, 2002
 

  As described in the above, Wyeth Korea, Inc. has contributed to the national health and the development of pharmaceutical industry through the introduction of innovating treatment drugs to Korea for the past 20 years. The company will do its best to promote the national health by supplying innovating new drugs continuously through the supply line of new drugs from its head office which is equipped with the greatest ability to do research and development in the future.